Research ArticleOriginal Article
Open Access

Clinical otorhinolaryngological presentation of COVID-19 patients in Saudi Arabia

A multicenter study

Laila M. Telmesani, Danah H. Althomaly, Lamia A. Buohliqah, Roa T. Halawani, Mona M. Ashoor, Marwan J. Alwazzeh, Suad A. Al Mubarak, Maha A. AlHarbi, Rana F. AlMuslem, Sahal S. Arabi, Waleed E. Saleh, Amal Y. ALYosif, Mohammad R. Al Eid, Lena S. Telmesani and Abdulaziz S. AlEnazi
Saudi Medical Journal March 2022, 43 (3) 266-274; DOI: https://doi.org/10.15537/smj.2022.43.3.20210501

References

  1. 1.↵
    1. Dogra A,
    2. Goyal B,
    3. Sharma AM.
    Corona virus: a novel outbreak. Biomed Pharmacol J 2020; 13: 5–10.
    OpenUrl
  2. 2.↵
    Daily briefing: WHO describes coronavirus as a pandemic to spur countries to action. Nature. [Updated 2020; 2020 Jan]. Available from: https://www.nature.com/articles/d41586-020-00732-y
  3. 3.↵
    1. Barry M,
    2. Ghonem L,
    3. Alsharidi A,
    4. Alanazi A,
    5. Alotaibi N,
    6. Al-Shahrani F, et al.
    Coronavirus disease-2019 pandemic in the Kingdom of Saudi Arabia: mitigation measures and hospital preparedness. JNSM 2020; 3: 155–158.
    OpenUrl
  4. 4.↵
    1. Obied DA,
    2. Alhamlan FS,
    3. Al-Qahtani AA,
    4. Al-Ahdal MN.
    Containment of COVID-19: the unprecedented response of Saudi Arabia. J Infect Dev Ctries 2020; 14: 699–706.
    OpenUrl
  5. 5.↵
    1. Jayaweera M,
    2. Perera H,
    3. Gunawardana B,
    4. Manatunge J.
    Transmission of COVID-19 virus by droplets and aerosols: a critical review on the unresolved dichotomy. Environ Res 2020; 188: 109819.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Alsofayan YM,
    2. Althunayyan SM,
    3. Khan AA,
    4. Hakawi AM,
    5. Assiri AM.
    Clinical characteristics of COVID-19 in Saudi Arabia: a national retrospective study. J Infect Public Health 2020; 13: 920–925.
    OpenUrlPubMed
  7. 7.↵
    1. El-Anwar MW,
    2. Elzayat S,
    3. Fouad YA.
    ENT manifestation in COVID-19 patients. Auris Nasus Larynx 2020; 47: 559–564.
    OpenUrl
  8. 8.↵
    1. Xu XW,
    2. Wu XX,
    3. Jiang XG,
    4. Xu KJ,
    5. Ying LJ,
    6. Ma CL, et al.
    Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-CoV-2) outside of Wuhan, China: retrospective case series. BMJ 2020; 368: m606.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Özçelik Korkmaz M,
    2. Eğilmez OK,
    3. Özçelik MA,
    4. Güven M.
    Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. Eur Arch Otorhinolaryngol 2021; 278: 1675–1685.
    OpenUrl
  10. 10.↵
    1. Sedaghat AR,
    2. Gengler I,
    3. Speth MM.
    Olfactory dysfunction: a highly prevalent symptom of COVID-19 with public health significance. Otolaryngol Head Neck Surg 2020; 163: 12–15.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Salmon Ceron D,
    2. Bartier S,
    3. Hautefort C,
    4. Nguyen Y,
    5. Nevoux J,
    6. Hamel AL, et al.
    Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study. J Infect 2020; 81: 614–620.
    OpenUrl
  12. 12.↵
    1. Gane SB,
    2. Kelly C,
    3. Hopkins C.
    Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology 2020; 58: 299–301.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Mishra P,
    2. Gowda V,
    3. Dixit S,
    4. Kaushik M.
    Prevalence of new onset anosmia in COVID-19 patients: is the trend different between European and Indian population? Indian J Otolaryngol Head Neck Surg 2020; 72: 1–4.
    OpenUrlCrossRef
  14. 14.↵
    1. Menni C,
    2. Valdes AM,
    3. Freidin MB,
    4. Sudre CH,
    5. Nguyen LH,
    6. Drew DA, et al.
    Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med 2020; 26: 1037–1040.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Lechien JR,
    2. Chiesa-Estomba CM,
    3. De Siati DR,
    4. Horoi M,
    5. Le Bon SD,
    6. Rodriguez A, et al.
    Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020; 277: 2251–2261.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Chen N,
    2. Zhou M,
    3. Dong X,
    4. Qu J,
    5. Gong F,
    6. Han Y, et al.
    Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507–513.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Chary E,
    2. Carsuzaa F,
    3. Trijolet JP,
    4. Capitaine AL,
    5. Roncato-Saberan M,
    6. Fouet K, et al.
    Prevalence and recovery rrom olfactory and gustatory dysfunctions in COVID-19 infection: a prospective multicenter study. Am J Rhinol Allergy 2020; 34: 686–693.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Krajewska J,
    2. Krajewski W,
    3. Zub K,
    4. Zatoński T.
    COVID-19 in otolaryngologist practice: a review of current knowledge. Eur Arch Otorhinolaryngol 2020; 277: 1885–1897.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Vaira LA,
    2. Salzano G,
    3. Deiana G,
    4. De Riu G.
    Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope 2020; 130: 1787.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Giacomelli A,
    2. Pezzati L,
    3. Conti F,
    4. Bernacchia D,
    5. Siano M,
    6. Oreni L, et al.
    Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study. Clin Infect Dis 2020; 71: 889–890.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Guan WJ,
    2. Ni ZY,
    3. Hu Y,
    4. Liang WH,
    5. Ou CQ,
    6. He JX, et al.
    Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708–1720.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Mao L,
    2. Wang M,
    3. Chen S,
    4. He Q,
    5. Chang J,
    6. Hong C, et al.
    Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. SSRN Electron J 2020.
  23. 23.↵
    1. Lechien JR,
    2. Chiesa-Estomba CM,
    3. Place S,
    4. Van Laethem Y,
    5. Cabaraux P,
    6. Mat Q, et al.
    Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med 2020; 288: 335–344.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Hopkins C,
    2. Surda P,
    3. Kumar N.
    Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology 2020; 58: 295–298.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Lovato A,
    2. de Filippis C.
    Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms. Ear Nose Throat J 2020; 99: 569–576.
    OpenUrlPubMed
  26. 26.↵
    1. Kaye R,
    2. Chang CWD,
    3. Kazahaya K,
    4. Brereton J,
    5. Denneny JC 3rd.
    COVID-19 anosmia reporting tool: initial findings. Otolaryngol Head Neck Surg 2020; 163: 132–134.
    OpenUrlCrossRefPubMed
  27. 27.↵
    COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: epidemiology Report 7 (reporting week ending 19:00 AEDT 14 March 2020). Commun Dis Intell (2018) 2020; 44.
  28. 28.↵
    1. Tong JY,
    2. Wong A,
    3. Zhu D,
    4. Fastenberg JH,
    5. Tham T.
    The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 2020; 163: 3–11.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Moein ST,
    2. Hashemian SM,
    3. Mansourafshar B,
    4. Khorram-Tousi A,
    5. Tabarsi P,
    6. Doty RL.
    Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol 2020; 10: 944–950.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Vaira LA,
    2. Deiana G,
    3. Fois AG,
    4. Pirina P,
    5. Madeddu G,
    6. De Vito A, et al.
    Objective evaluation of anosmia and ageusia in COVID-19 patients: single-center experience on 72 cases. Head Neck 2020; 42: 1252–1258.
    OpenUrlCrossRefPubMed
  31. 31.↵
  32. 32.↵
    1. Jayaweera M,
    2. Perera H,
    3. Gunawardana B,
    4. Manatunge J.
    Transmission of COVID-19 virus by droplets and aerosols: a critical review on the unresolved dichotomy. Environ Res 2020; 188: 109819.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Białas AJ,
    2. Kumor-Kisielewska A,
    3. Górski P.
    Ageing, sex, obesity, smoking and COVID-19 - truths, myths and speculations. Adv Respir Med 2020; 88: 335–342.
    OpenUrlCrossRef
  34. 34.↵
    1. Peckham H,
    2. de Gruijter NM,
    3. Raine C,
    4. Radziszewska A,
    5. Ciurtin C,
    6. Wedderburn LR, et al.
    Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun 2020; 11: 6317.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Wang D,
    2. Hu B,
    3. Hu C,
    4. Zhu F,
    5. Liu X,
    6. Zhang J, et al.
    Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061–1069.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Liu H,
    2. Chen S,
    3. Liu M,
    4. Nie H,
    5. Lu H.
    Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis. Aging Dis 2020; 11: 668–678.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords